Regulatory Affairs Certification (RAC) 2025 – 400 Free Practice Questions to Pass the Exam

The abbreviation for the application submitted for premarket approval is PMA, which stands for Premarket Approval. This is a rigorous process that medical device manufacturers must go through to obtain FDA approval for devices that are considered high-risk. The PMA process requires manufacturers to provide substantial evidence of safety and effectiveness, typically through clinical trials, before their product can be marketed in the United States.

Understanding the significance of the PMA is essential in regulatory affairs, as it indicates a comprehensive regulatory pathway for devices that need extensive testing and validation due to their complexity or potential impact on patient health. This process is distinct from other regulatory submissions like an IND (Investigational New Drug application), which is relevant for drugs being tested in clinical trials but not for medical devices, or a PDR (Product Development Report), which may refer to other aspects of product development or can be associated with various stages of submission depending on context. PMS, or Post-Market Surveillance, is focused on monitoring the safety and effectiveness of products already on the market and is not relevant to the initial approval process.